Karius
Throughout his academic career, Dr. Bercovici has been developing novel mathematical models and algorithms that address broad challenges in genetics and the study of human disease, with immediate implications for preventive and therapeutic solutions. Prior to Karius, Dr. Bercovici was a co-founder and Chief Technology Officer at Lifecode, where he led the development of Lifecode’s analytical platform and validation of several clinical assays based on next-generation sequencing. He holds a Ph.D. in Computer Science from the Technion – Israel Institute of Technology.
Karius
2 followers
Karius sees a world where infectious disease is no longer a major threat to human health. To achieve this, the Karius Test enables mapping of the patient’s microbial landscape from a single blood sample to enable physicians to make rapid treatment decisions.